[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Xiuhua Sun\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":44},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":4},"100574640",false,"NCT06761911","BV in the Treatment of Relapsed\u002Frefractory Hodgkin Lymphoma","A Real-world Study of Brentuximab Vedotin Monotherapy and Combination Regimens in the Treatment of Relapsed\u002FRefractory Hodgkin Lymphoma","Inclusion Criteria:\n\n* Histologically, classical hodgkin lymphoma（cHL） was diagnosed and relapsed or refractory.\n* Patients were treated with BV-containing regimen at least once\n* Presence of tumor (measurable or nonmeasurable).\n* Signature of the form consent for participation in the study.\n\nExclusion Criteria:\n\n* \\\u003C18 years","ALL","18 Years",{"count":18,"type":19},100,"ESTIMATED","INTERVENTIONAL",[22],"PHASE4","The goal of this clinical trial is to explore the real-world Chinese relapsed\u002Frefractory patients to evaluate the efficacy and safety of BV monotherapy or combination therapy in CHL patients. The main questions it aims to answer are:\n\nTo evaluate the efficacy and toxicity of BV-containing regimen in relapsed\u002Frefractory CHL patients in China, and to provide reference for the rational and safe use of BV in clinical practice.",[25],"Hodgkin Lymphoma (Category)",[27,28,29,30,31],"Brentuximab Vedotin","Hodgkin lymphoma","refractory recurrence","real world","china","NOT_YET_RECRUITING","2025-01-06",{"date":35,"type":36},"2025-01-07","ACTUAL",{"date":38,"type":19},"2024-12-31",{"date":40,"type":19},"2026-01-31",{"name":42,"class":43},"Xiuhua Sun","OTHER",""]